The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p

Abstract

This study suggested that LINC00922 could competitively bind with miR-361-3p to promote the CLDN1 expression and activate Wnt/β-catenin signaling in OC progression, which providing a promising therapeutically target for OC.